Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems

Garabedian, Pamela M.; Wright, Adam; Newbury, Isabella; Salazar, Alejandra; Amato, Mary G.; Nathan, A W; Forsythe, Katherine; Galanter, William L.; Kron, Kevin; Myers, Sara; Abraham, Joanna; McCord, Sarah; Eguale, Tewodros; Bates, David W.; Schiff, Gordon D.

doi:10.1001/jamanetworkopen.2019.1514

Cited by 18 publications

(34 citation statements)

References 16 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The latter study by Garada, Schiff, and colleagues involved researchers interviewing patients regarding the use of putting RFU on medication labels indications as well. Additional work by Schiff and colleagues has examined the addition of medication indications via "indications based" prescribing to allow for easier and faster addition of medication indications, to enhance medication safety, and to improve clinician communication [6,30,31]. This paper builds on this existing work by highlighting some additional benefits to adding RFU on medication labels, such as keeping track of medication despite changes in brand or packaging and the value in having RFU on medications in emergency situations.…”

Section: Discussionmentioning

confidence: 99%

How do I keep myself safe? Patient perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis

Whaley

Bancsi

et al. 2020

J of Pharm Policy and Pract

View full text Add to dashboard Cite

Background Medications are crucial for maintaining patient wellness and improving health in modern medicine, but their use comes with risks. Helping patients to understand why they are taking medications is important for patient-centered care and facilitates patient adherence to prescribed medications. One strategy involves enhancing communication between patients, physicians, and pharmacists through the sharing of reason for use (RFU) information or the indication for medications. Methods Semi-structured interviews were conducted with 20 patients in Ontario, Canada, to gain perspectives on how patients currently store their medication information and benefits and disadvantages of adding RFU to prescriptions and medication labels. An interview guide was used by the two interviewers, and the interviews were recorded, transcribed, and thematically coded. Results The analysis yielded three main themes: patient decision making with RFU, RFU in modern, patient-centered care, and logistical aspects of communicating RFU. The patients that were interviewed expressed the value of having RFU when deciding if a medication was effective or to stop taking the medication. Patients felt comfortable with RFU being added to prescriptions and acknowledged the value in adding RFU to medication labels, helping patients and others identify and distinguish medications. Patients generally expressed interest in having RFU written in lay language and identified strengths and weaknesses of having access to RFU via a website or app. Conclusions Patients rated the importance of knowing RFU very highly, identified the value in sharing RFU with pharmacists on prescriptions, and in having RFU on medication labels. These results can be used to inform policy on the addition of RFU on prescriptions and medication labels and support improved communication between patients, pharmacists, and physicians about RFU.

show abstract

Section: Discussionmentioning

confidence: 99%

How do I keep myself safe? Patient perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis

Whaley

Bancsi

et al. 2020

J of Pharm Policy and Pract

View full text Add to dashboard Cite

show abstract

“…[7][8][9] Adding RFU to prescriptions and medication labels presents clear benefits to all health care providers and patients but is still not part of routine clinical practice. 10 This paper explores the potential impact that adding RFU to prescriptions could have on pharmacy practice. The value of this research is hearing directly from pharmacists about how having access to RFU would affect their clinical workflow and the care provided to patients.…”

Section: Colin Whaleymentioning

confidence: 99%

Pharmacists’ perspectives on the value of reason for use information

Whaley¹,

Bancsi²,

Burns³

et al. 2020

Can Pharm J

View full text Add to dashboard Cite

Background: The indication for a particular medication, or its reason for use (RFU), is important information for prescribers, pharmacists and patients but is not often communicated in writing from prescribers to pharmacists. Adding RFU to a prescription and a medication label would ensure that pharmacists are confident that they are providing high-quality, accurate patient care. This study aims to describe the perspectives of pharmacists on how receiving RFU from prescribers would affect their practice and how pharmacists putting this information on prescriptions would affect patients. Methods: Semi-structured qualitative interviews were conducted with 20 pharmacists in Southwestern Ontario. Thematic analysis was used to analyze the interview transcripts, leading to 4 major themes. Results: Pharmacists expressed that RFU should be formatted to ensure that it is of clinical utility via the use of written text and noted that either medical or lay (also known as plain) language would be appropriate for use. Pharmacists indicated that patient privacy should be considered when writing RFU on labels and that patient preference with respect to the addition of RFU should dictate its inclusion on a medication label. Pharmacist access to RFU was universally acknowledged to improve patient safety by providing pharmacists with more information to determine whether the given medication was indicated. Conclusions: This study provides further information about the impact that having access to RFU would have on pharmacy practice and can be used to advocate for the inclusion of RFU information with prescriptions to improve patient outcomes. Can Pharm J (Ott) 2020;153:xx-xx.

show abstract

“…In a recent usability evaluation of a prototype of this functionality, indications-based prescribing was more efficient to use, resulted in fewer medication errors and in higher usability scores than the traditional EPS functionality. 6 For example, a doctor said: "You don't really think about it like, this patient has heart failure and therefore I am going to prescribe this medication. I know it should be that way but it doesn't really happen.…”

Section: Introductionmentioning

confidence: 99%